PCM
LLY icon

Prelude Capital Management’s Eli Lilly LLY Stock Holding History

Prelude Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,100
Closed -$123K – 2105
2019
Q3 		$123K Buy
+1,100
New +$122K 0.01% 888
2019
Q2 		– Sell
-25,000
Closed -$3.24M – 1927
2019
Q1 		$3.24M Buy
25,000
+24,900
+24,900% +$3.03M 0.18% 100
2018
Q4 		$12K Buy
+100
New +$11.2K ﹤0.01% 1338

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Prelude Capital Management's LLY Position: Q2 2026 in Review

Prelude Capital Management reduced its Eli Lilly (LLY) stake by 10% in Q2 2026, selling an estimated $293K and leaving 2,543 shares worth $3.05M. The position accounts for 0.22% of the portfolio, ranked #111.

Prelude Capital Management first reported a position in LLY in Q2 2013 and has held it in 41 quarters since. The position peaked at $6.91M in Q2 2024. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Prelude Capital Management held 2,543 shares of Eli Lilly worth $3.05M as of Q2 2026.
  • Prelude Capital Management sold 287 Eli Lilly shares in Q2 2026, an estimated $293K.
  • Eli Lilly made up 0.22% of Prelude Capital Management's portfolio in Q2 2026, its #111 holding.
  • Prelude Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 41 quarters since.
  • Prelude Capital Management's Eli Lilly position peaked at $6.91M in Q2 2024.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.